Collaborative Research Inc. (NASDAQ:CRIC) of Waltham, Mass.,received a $500,000, two-year Phase II small businessinnovation research (SBIR) grant from the National Institute ofGeneral Medical Sciences to develop a multiplex DNA diagnostictest technology. The initial target will be for multiple mutantalleles of the CFTR gene that is responsible for cystic fibrosis.

(c) 1997 American Health Consultants. All rights reserved.

No Comments